Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam dose comparison for loss of consciousness during general anesthesia induction in elderly vs non-elderly day-surgery patients
ChiCTR2400091138Phase 4Not yet recruiting
- Sponsor
- The First People's Hospital of Linping District, Hangzhou
- Start
- Oct 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of remimazolam and sufentanil in perioperative sedation (8 arms), sponsored by The First People's Hospital of Linping District, Hangzhou. Primary endpoint: Bispectral Index. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
remimazolamsufentanil
03
Conditions
perioperative sedation
Beyond the preview
Go deeper on ChiCTR2400091138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091138.